Designed for patients needing a replacement valve, the company’s TAVI trial has found low rates of mortality after a year of ...

Edwards Lifesciences (EW) announced one-year data highlighting the continued performance of its SAPIEN 3 Ultra RESILIA valve. The data were ...

Prolonged sitting doesn’t just hurt your back; it significantly increases the risk of heart failure and cardiovascular death, ...

A recent study published in the Journal of the American College of Cardiology found that prolonged sitting increases the risk ...

New research published in the Journal of the American College of Cardiology has shown that spending 10.6 or more hours per ...

A recent study in the Journal of the American College of Cardiology offers a compelling reason to rethink our sedentary ...

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, ...

Edwards Lifesciences (NYSE:EW) today announced one-year data highlighting strong performance from its Sapien 3 Ultra Resilia ...

People who spend more than ten hours a day sitting have a higher risk of getting heart failure and other cardiovascular ...

A collection of studies presented at a recent American Heart Association (AHA) conference has confirmed the heart health benefits provided by the new anti-obesity drugs, semaglutide and tirzepatide, ...

and CV mortality,” the authors wrote in the Nov. 15 study published in the Journal of the American College of Cardiology.

Between 2008 and 2019, the share of cardiologists practicing in a hospital, as opposed to an independent practice, increased from 26% to 63%, according to a study published Nov. 15 in the Journal of ...